Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.

@article{Dinmohamed2014TrendsII,
  title={Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.},
  author={Avinash G Dinmohamed and Otto J. Visser and Yvette van Norden and Peter C. Huijgens and P. Sonneveld and Arjan A. van de Loosdrecht and Mojca Jongen-Lavrencic},
  journal={European journal of cancer},
  year={2014},
  volume={50 5},
  pages={
          1004-12
        }
}
BACKGROUND Studies with long-term follow-up of patients with myelodysplastic syndromes (MDS) based on data from nationwide population-based cancer registries are lacking. We conducted a nationwide population-based study to assess trends in incidence, initial treatment and survival in MDS patients diagnosed in the Netherlands from 2001 to 2010. METHODS We identified 5144 MDS patients (median age, 74 years) from the Netherlands Cancer Registry (NCR). The NCR only includes MDS cases that were… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

Diagnostics and Prognostication of Myelodysplastic Syndromes

  • Annals of laboratory medicine
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND